SAN's Business Restructuring Initiatives Driving Growth: Time to Buy? — Positive
SAN Zacks Investment Research — May 12, 2025Is now the right time to buy Banco Santander's shares as the One Transformation program continues to support its financials? Let's have a closer look.
Ardmore Shipping Corporation (ASC) is Attracting Investor Attention: Here is What You Should Know — Positive
ASC Zacks Investment Research — May 12, 2025Recently, Zacks.com users have been paying close attention to Ardmore Shipping (ASC). This makes it worthwhile to examine what the stock has in store.
Here is What to Know Beyond Why DraftKings Inc. (DKNG) is a Trending Stock — Positive
DKNG Zacks Investment Research — May 12, 2025DraftKings (DKNG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why Cloudflare, Inc. (NET) is a Trending Stock — Positive
NET Zacks Investment Research — May 12, 2025Cloudflare (NET) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why Occidental Petroleum Corporation (OXY) is a Trending Stock — Positive
OXY Zacks Investment Research — May 12, 2025Occidental (OXY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation — Neutral
CYTK Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK). Investors who purchased Cytokinetics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CYTK.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Watsco, Inc. (WSO) and Encourages Stockholders to Learn More About the Investigation — Neutral
WSO Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Watsco, Inc. ("Watsco" or "the Company") (NYSE: WSO). Investors who purchased Watsco securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WSO.
TaskUs, Inc. (TASK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
TASK Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TaskUs, Inc. ("TaskUs" or "the Company") (NASDAQ:TASK). Investors who purchased TaskUs securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TASK.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Jack in the Box Inc. (JACK) and Encourages Stockholders to Learn More About the Investigation — Neutral
JACK Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jack in the Box Inc. ("Jack in the Box" or "the Company") (NASDAQ:JACK). Investors who purchased Jack in the Box securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/JACK.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Investors to Learn More About the Investigation — Neutral
OGN Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: OGN). Investors who purchased Organon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OGN.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Cable One, Inc. (CABO) And Encourages Stockholders to Connect — Neutral
CABO Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cable One, Inc. ("Cable One" or "the Company") (NYSE:CABO). Investors who purchased Cable One securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CABO.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Kohl's Corporation (KSS) And Encourages Investors to Connect — Neutral
KSS Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kohl's Corporation ("Kohl's" or "the Company") (NYSE:KSS). Investors who purchased Kohl's securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/KSS.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Amerant Bancorp Inc. (AMTB) And Encourages Stockholders to Connect — Neutral
AMTB Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. ("Amerant" or "the Company") (NYSE:AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMTB.
Bronstein, Gewirtz & Grossman, LLC Is Investigating PTC Therapeutics, Inc. (PTCT) And Encourages Investors to Connect — Neutral
PTCT Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.
Affirm's Inflection Is Here - Possible Near Doubling Upside — Positive
AFRM Seeking Alpha — May 12, 2025AFRM's focus on 0% APR offerings have already triggered improved consumer acquisition trends and healthier risk profile, during an uncertain macro environment. The BNPL company has also reached an improved operating scale, as observed in its positive profit margins and raised FY2025 guidance. While AFRM may appear to be trading at a notable premium at current levels, the stock continues to offer rich double digits upside potential, if not, near doubling.
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation — Neutral
HUM Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). Investors who purchased Humana securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/HUM.
Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Stockholders to Inquire about Securities Investigation — Neutral
SLQT Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SLQT.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Investors to Learn More About the Investigation — Neutral
ARVN Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. ("Arvinas" or "the Company") (NASDAQ:ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ARVN.
FTI Consulting, Inc. (FCN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
FCN Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FTI Consulting, Inc. ("FTI" or "the Company") (NYSE: FCN). Investors who purchased FTI securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FCN.
